Notably, the upregulation of several of these genes, particularly NCF1, HSPB1, PIGT, and PTX3, was associated with poor prognosis, supporting the idea that these genes play a pivotal role in tumor progression and patient survival. Here, PTX3 is linked to neoplasm.